Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China
Cancer Medicine · 2023-04 · 12 (8) · 9332-9350
DOI: 10.1002/cam4.5690 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Cancer Medicine, online erschienen am 17.02.2023. Verfasst von Junnan Li und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Myeloproliferative Disorders, Myelodysplastic Syndromes. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Myeloid neoplasms (MN) tend to relapse and deteriorate. Exploring the genomic mutation landscape of MN using next‐generation sequencing (NGS) is a great measure to clarify the mechanism of oncogenesis and progression of MN.
Methods
This multicenter retrospective study investigated 303 patients with MN using NGS from 2019 to 2021. The characteristics of the mutation landscape in the MN subgroups and the clinical value of gene variants were analyzed.
Results
At least one mutation was detected in 88.11% of the patients (267/303). TET2 was the most common mutation in the cohort, followed by GATA2, ASXL1, FLT3, DNMT3A , and TP53 . Among patients with myeloid leukemia (ML), multivariate analysis showed that patients aged ≥60 years had lower overall survival (OS, p = 0.004). Further analysis showed TET2, NPM1, SRSF2 , and IDH1 gene mutations, and epigenetic genes ( p < 0.050) presented significantly higher frequency in older patients. In patients with myelodysplastic syndrome (MDS) and myelodysplastic neoplasms (MPN), univariate analysis showed that BCORL1 had a significant impact on OS ( p = 0.040); however, in multivariate analysis, there were no factors significantly associated with OS. Differential analysis of genetic mutations showed FLT3, TP53, MUC16, SRSF2 , and KDM5A mutated more frequently ( p < 0.050) in secondary acute myeloid leukemia (s‐AML) than in MDS and MPN. TP53, U2AF1, SRSF2 , and KDM5A were mutated more frequently ( p < 0.050) in s‐AML than in primary AML. KDM5A was observed to be restricted to patients with s‐AML in this study, and only co‐occurred with MUC16 and TP53 (2/2, 100%). Another mutation was MUC16 , and its co‐occurrence pattern differed between s‐AML and AML. MUC16 mutations co‐occurred with KDM5A and TP53 in 66.7% (2/3) of patients with s‐AML and co‐occurred with CEBPA in 100% (4/4) of patients with AML.
Conclusions
Our results demonstrate different genomic mutation patterns in the MN subgroups and highlight the clinical value of genetic variants.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, People's Republic of China.
- Department of Hematology, The First Affiliated Hospital of Army Medical University(Southwest Hospital), Chongqing, China.
- Department of Hematology, Shaanxi Provincial People's Hospital, Xi'An, Shaanxi, China.
- Department of Oncology and Hematology, Chongqing University Affiliated Center Hospital, Chongqing, China.
ORCID-Profile: Li Wang
Zitieren
APA
Li, J., Pei, L., Liang, S., Xu, S., Wang, Y., Wang, X., Liao, Y., Zhan, Q., Cheng, W., Yang, Z., Tang, X., Zhang, H., Xiao, Q., Chen, J., Liu, L., & Wang, L. (2023). Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China. Cancer Medicine, 12(8), 9332-9350. https://doi.org/10.1002/cam4.5690
Vancouver
Li J, Pei L, Liang S, Xu S, Wang Y, Wang X, et al. Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China. Cancer Medicine. 2023;12(8):9332-9350. doi:10.1002/cam4.5690
BibTeX
@article{Li2023,
author = {Li, Junnan and Pei, Li and Liang, Simin and Xu, Shuangnian and Wang, Yi and Wang, Xiao and Liao, Yi and Zhan, Qian and Cheng, Wei and Yang, Zesong and Tang, Xiaoqiong and Zhang, Hongbin and Xiao, Qing and Chen, Jianbin and Liu, Lin and Wang, Li},
title = {Gene mutation analysis using next‐generation sequencing and its clinical significance in patients with myeloid neoplasm: A multi‐center study from China},
journal = {Cancer Medicine},
year = {2023},
volume = {12},
number = {8},
pages = {9332--9350},
doi = {10.1002/cam4.5690}
}
EUVIMED